Journal Article Summary
The article investigates the effects of native vitamin D supplementation in patients with end-stage kidney disease (ESKD), a condition where vitamin D deficiency is common. This topic is significant because vitamin D is known to play roles beyond bone health, potentially influencing cardiovascular health, immune function, and overall well-being. Despite the high prevalence of vitamin D deficiency in ESKD patients, clinical guidelines have primarily recommended the use of the active form of vitamin D rather than addressing the deficiency itself. The authors aimed to clarify whether correcting vitamin D deficiency in this population could lead to improved health outcomes.
The researchers conducted a systematic review of randomized controlled trials involving 2,489 adults with ESKD to assess the impact of vitamin D supplementation on various health outcomes, including mortality, cardiovascular health, inflammation, muscle function, and overall patient well-being. They found that while vitamin D supplementation effectively corrected deficiency, it showed minimal and inconsistent benefits across the studied outcomes. Notably, the largest trials indicated that vitamin D did not significantly affect patient-reported well-being, inflammation levels, or the use of erythropoietin, a medication commonly used in ESKD treatment.
The study has limitations, including the small size of many trials and the variability in outcomes measured, which prevented a comprehensive meta-analysis. Additionally, while vitamin D supplementation was generally safe and well-tolerated, the lack of clear evidence supporting its benefits on various health outcomes raises questions about its role in ESKD management. Patients and caregivers should discuss these findings with healthcare professionals to better understand the implications for treatment and whether vitamin D supplementation is appropriate for their specific situation.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Pilkey Nathan G., Novosel Olivia, Roy Angélique, Wilson Tristin E., Sharma Jaya, Khan Sono, Kapuria Sanjana, Adams Michael A., et al.. Does Native Vitamin D Supplementation Have Pleiotropic Effects in Patients with End-Stage Kidney Disease? A Systematic Review of Randomized Trials. Nutrients 2023. DOI: 10.3390/nu15133072. PMID: 37447398. PMCID: PMC10346817.
Featured Pill Pals Product
Ergocalciferol 1,250 mcg Capsules --- 4 Count / Taken Once A Week --- Generic for Drisdol --- Bion Pharma
Ergocalciferol 1,250 mcg Capsules — 4 Count / Taken Once A Week — Generic for Drisdol — Bion Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
